Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis (2009)

  • Authors:
  • USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; PEREIRA, ROSA MARIA RODRIGUES - FM
  • USP Schools: FM; FM
  • DOI: 10.1007/s10067-009-1153-8
  • Subjects: VASCULITE; LIPOPROTEÍNAS (NÍVEL); FATORES DE RISCO; DOENÇAS CARDIOVASCULARES; ARTERITE DE TAKAYASU; BIOMARCADORES
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s10067-009-1153-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Clinical Rheumatology

    ISSN: 0770-3198

    Citescore - 2017: 2.04

    SJR - 2017: 0.93

    SNIP - 2017: 0.877


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700094199-SFM BCBIB
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CARVALHO, Jozélio Freire de; PEREIRA, Rosa Maria Rodrigues; BONFÁ, Eloísa Silva Dutra de Oliveira; BEZERRA, Mailze C. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clinical rheumatology, London, v. 28, n. 7, p. 801-805, 2009. DOI: 10.1007/s10067-009-1153-8.
    • APA

      Carvalho, J. F. de, Pereira, R. M. R., Bonfá, E. S. D. de O., & Bezerra, M. C. (2009). High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clinical rheumatology, 28( 7), 801-805. doi:10.1007/s10067-009-1153-8
    • NLM

      Carvalho JF de, Pereira RMR, Bonfá ESD de O, Bezerra MC. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clinical rheumatology. 2009 ; 28( 7): 801-805.
    • Vancouver

      Carvalho JF de, Pereira RMR, Bonfá ESD de O, Bezerra MC. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clinical rheumatology. 2009 ; 28( 7): 801-805.

    Referências citadas na obra
    Yamato M, Lecky JW, Hiramatsu K, Kohda E (1986) Takayasu arteritis: radiographic and angiographic findings in 59 patients. Radiology 161:329–334
    Numano F (2002) Takayasu's arteritis: clinical aspects. In: Hoffman GS, Weyand CM (eds) Inflammatory diseases of blood vessels. Marcel Dekker, New York, pp 455–466
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–192
    Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2496
    Numano F (2000) Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 75(Suppl 1):S1–S8
    Numano F, Kishi Y, Tanaka A, Ohkawara M, Kakuta T, Kobayashi Y (2000) Inflammation and atherosclerosis. Atherosclerotic lesions in Takayasu arteritis. Ann NY Acad Sci 902:65–76
    Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu's arteritis. Lancet 356:1023–1025
    Filer A, Nicholls D, Corston R, Carey P, Bacon P (2001) Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage. J Rheumatol 28:2752–2753
    Sun Y, Yip PK, Jeng JS, Hwang BS, Lin WH (1996) Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke 27:2178–2182
    Sharma S, Sharma S, Taneja K, Gupta AK, Rajani M (1996) Morphologic mural changes in the aorta revealed by CT in patients with nonspecific aortoarteritis (Takayasu's arteritis). Am J Roentgenol 167:1321–1325
    Taniguchi N, Itoh K, Honda M, Obayashi T, Nakamura M, Kawai F et al (1997) Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis. Angiology 48:9–20
    Lefebvre C, Rance A, Paul JF, Beguin C, Bletry O, Amoura Z et al (2000) The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients. Semin Arthritis Rheum 30:25–32
    Park SH, Chung JW, Lee JW, Han MH, Park JH (2001) Carotid artery involvement in Takayasu's arteritis: evaluation of the activity by ultrasonography. J Ultrasound Med 20:371–378
    Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, Yazici H (2006) Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65:1202–1207
    Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134
    Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919–929
    Bezerra MC, Calomeni GD, Caparbo VF, Gebrim ES, Rocha MS, Pereira RM (2005) Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Rheumatol (Oxford) 44:1503–1506
    Siedel J, Hägele EO, Zielgenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075–1080
    Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077–2080
    Warnick GR, Cheung NC, Albers JJ (1979) Comparison of current methods for high density lipoprotein cholesterol quantification. Clin Chem 25:596–604
    Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
    Williams CM (2004) Lipid metabolism in women. Proc Nutr Soc 63:153–160
    Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S (2007) Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 4(Suppl B):S162–S177
    Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G et al (1980) Lipoprotein-cholesterol distribution in selected North American populations: the lipid research clinics program prevalence study. Circulation 61:302–315
    Kannel WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 85:447–452
    Brown WV (1994) Lipoprotein disorders in diabetes mellitus. Med Clin North Am 78:143–161
    Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB (1981) Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 78:2591–2595
    Attman PO, Alaupovic P (1991) Lipid and apolipoprotein profiles of uremic dyslipoproteinemia—relation to renal function and dialysis. Nephron 57:401–410
    Seko Y (2007) Giant cell and Takayasu arteritis. Curr Opin Rheumatol 19:39–43
    Nashel DJ (1986) Is atherosclerosis a complication of long-term corticosteroid treatment. Am J Med 80:925–929
    Al Rayyes O, Wallmark A, Florén CH (1997) Additive inhibitory effect of hydrocortisone and cyclosporine on low-density lipoprotein receptor activity in cultured HepG2 cells. Hepatology 26:967–971
    Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615–1622
    Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26:1701–1704
    Borba EF, Bonfá E (1997) Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 6:533–539
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E (2004) Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 50:3610–3615
    Quéméneur T, Martin-Nizard F, Kandoussi A et al (2007) PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis. Semin Arthritis Rheum 37:149–155